Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Polar Capital Holdings Plc reported a 5.28% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Polar Capital Holdings Plc reported a 5.28% stake in Arcutis Biotherapeutics, Inc., 6,606,945 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.28%
- Shares
- 6,606,945
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Polar Capital Holdings Plc | 5.28% | 6,606,945 |
| Polar Capital LLP | 5.28% | 6,606,945 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Polar Capital Holdings Plc
- Arcutis Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Polar Capital Holdings Plc · Aug 14, 2025
- Schedule 13G/A · Polar Capital Holdings Plc · May 15, 2025
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026